Cargando…
Research on Liver Damage Caused by the Treatment of Rheumatoid Arthritis with Novel Biological Agents or Targeted Agents
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by polyarticular, symmetric, and aggressive inflammation of the small joints in the hands and feet, resulting in dysfunction. With progress and development in medicine, treatment of RA is constantly evolving, making several drug...
Autores principales: | Zhao, Xin, Zhang, Chenhao, An, Yi, Zhang, Zixuan, Zhao, Jiahe, Zhang, Xinwen, Yang, Yue, Cao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904211/ https://www.ncbi.nlm.nih.gov/pubmed/36761903 http://dx.doi.org/10.2147/JIR.S395137 |
Ejemplares similares
-
Rheumatoid arthritis‐associated interstitial lung disease hotspots and future directions: A Web‐of‐Science based scientometric and visualization study
por: Yang, Yue, et al.
Publicado: (2023) -
Damage progression in rheumatoid arthritis: the role of biologic agents
por: Favalli, Ennio Giulio
Publicado: (2012) -
Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
por: Mahlich, Jörg, et al.
Publicado: (2016) -
Dopaminergic Agents in Rheumatoid Arthritis
por: Capellino, Silvia
Publicado: (2019) -
Biologic agents for rheumatoid arthritis—negotiating the NICE technology appraisals
por: Kiely, Patrick D. W., et al.
Publicado: (2012)